iodine-131 monoclonal antibody 3F8
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for iodine-131 monoclonal antibody 3F8, covering 2024-04-04 to 2024-04-04. Get the full timeline:
Most recent: Clinical Trial Update: Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer [Phase 2]